- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
该股进入多头行情中，股价短线上涨概率较大。
- 中期趋势：
正处于反弹阶段。
- 长期趋势：
已有1家主力机构披露2026-06-30报告期持股数据，持仓量总计10.04万股，占流通A股0.01%
- 波段诊断：
-
技术面诊股
诊断结果：6.5技术面打败了66%的股票
技术面评分前10的股票
近期的平均成本为8.38元。空头行情中，目前正处于反弹阶段，投资者可适当关注。
平均成本
近期的平均成本为8.38元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"8.38","date":1786003867,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势跑赢大盘，接近行业平均水平。
[{"date":"2026.08.07","stock":"4.27","trade":"6.42","ind":"1.42"},{"date":"2026.08.06","stock":"-1.09","trade":"-0.94","ind":"-0.24"},{"date":"2026.08.05","stock":"-1.19","trade":"1.26","ind":"1.86"},{"date":"2026.08.04","stock":"0.36","trade":"2.90","ind":"3.25"},{"date":"2026.08.03","stock":"1.21","trade":"0.14","ind":"-0.96"},{"date":"2026.07.31","stock":"0.36","trade":"2.21","ind":"2.21"},{"date":"2026.07.30","stock":"0.24","trade":"-2.19","ind":"-2.73"},{"date":"2026.07.29","stock":"1.48","trade":"0.94","ind":"1.10"},{"date":"2026.07.28","stock":"-0.49","trade":"-1.95","ind":"-4.52"},{"date":"2026.07.27","stock":"3.30","trade":"3.13","ind":"2.72"},{"date":"2026.07.24","stock":"-4.14","trade":"-3.95","ind":"-2.47"},{"date":"2026.07.23","stock":"-0.61","trade":"-0.26","ind":"0.44"},{"date":"2026.07.22","stock":"-1.20","trade":"-0.90","ind":"-1.42"},{"date":"2026.07.21","stock":"0.36","trade":"-0.66","ind":"4.81"},{"date":"2026.07.20","stock":"1.83","trade":"0.38","ind":"-0.71"},{"date":"2026.07.17","stock":"-5.98","trade":"-7.01","ind":"-5.40"},{"date":"2026.07.16","stock":"-0.91","trade":"0.36","ind":"-1.97"},{"date":"2026.07.15","stock":"2.21","trade":"2.67","ind":"-0.97"},{"date":"2026.07.14","stock":"0.35","trade":"2.74","ind":"2.77"},{"date":"2026.07.13","stock":"4.01","trade":"-1.36","ind":"-3.48"},{"date":"2026.07.10","stock":"1.60","trade":"3.33","ind":"-2.29"}]
安科生物,深证成指,生物制品指数
压力支撑
该股压力位为8.30元，支撑位为8.05元。
[{"text":"\u538b\u529b\u4f4d","value":"8.30","date":1786032000,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"8.05","date":1786032000,"color":"0x0b52a1"}]
多空趋势
空头行情中，目前正处于反弹阶段，投资者可适当关注。
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：4.4资金面打败了60%的股票
主力控盘前10的股票
行业资金
生物制品行业， 近5日资金总体呈流入状态，投资者可考虑关注该行业的个股。
更新时间：08月07日 20:30
| 机构今日流向(万元) | 4792.39 | 机构5日流向(万元) | 1320.97 |
| 机构10日流向(万元) | 1691.82 | 机构20日流向(万元) | -1208.80 |
机构持仓
2026-06-30 与 2025-12-31 相比，主力机构持仓量减少11825.3万股，其中基金净增仓1家，主力净减仓140家，暂未发现中长期投资价值。
截止2026-06-30，共1家主力机构（基金1家），持仓量总计10.04万股，占流通A股0.01%
其中，基金持仓与2025-12-31相比：
增仓：1家 ，增持 8.40万股
减仓：0家 ，减持 0万股
新出现在主力名单中：0家 ，持有万股
从主力名单中消失：140家 ，原持有11833.7万股
其中，基金持仓与2025-12-31相比：
增仓：1家 ，增持 8.40万股
减仓：0家 ，减持 0万股
新出现在主力名单中：0家 ，持有万股
从主力名单中消失：140家 ，原持有11833.7万股
消息面诊股
诊断结果：5消息面打败了26%的股票
今日有利好新闻的公司
近期该股消息很少，消息面信号较弱。
更多>>个股资讯
- 天弘国证生物医药ETF发起式联接A重仓股安科生物涨
2026-08-07 - 安科生物：8月6日获融资买入1265.60万元
2026-08-07 - 从生物医药“链主”到全新视界
2026-08-07 - “药”创新 “屏”实力 合肥科创活力奔涌不息
2026-08-07 - 安科生物筑强创新底盘 合肥生物医药产业蓄势腾飞
2026-08-06 - 安科生物：8月5日获融资买入1563.34万元
2026-08-06 - “药”创新 “屏”实力 合肥科技创新活力竞相迸发
2026-08-06 - 安科生物：多肽原料药先行突破，稳步推进出海战略
2026-08-05 - 安科生物：8月4日获融资买入1427.64万元
2026-08-05 - 安科生物多肽原料药国际化再获突破，奥曲肽原料药取得
2026-08-04
消息列表
| 一般消息 | 股东大会 | 年度股东大会 | 2026-03-31 |
| 利好 | 分红转增 | 10派2.5元(含税) | 2026-03-31 |
| 利好 | 重大事项 | 参股拟上市公司或非上市公司金融机构 | 2025-12-31 |
| 一般消息 | 高管变动 | 取消监事会 | 2025-12-18 |
| 一般消息 | 重大事项 | 关联交易 | 2025-11-11 |
| 一般消息 | 分红转增 | 不分配不转增 | 2025-08-22 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 2条 | 0条 | 2条 |
| 利空 | 0条 | 0条 | 0条 |
行业面诊股
诊断结果：8.3行业面打败了91%的股票
生物制品行业最新资金流向
近10日来该行业走势明显向上，明显跑赢大盘。最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
行业走势
近10日来该行业走势明显向上，明显跑赢大盘。
[{"date":"2026.08.07","price":"1.42","value":"6.42"},{"date":"2026.08.06","price":"-0.24","value":"-0.94"},{"date":"2026.08.05","price":"1.86","value":"1.26"},{"date":"2026.08.04","price":"3.25","value":"2.90"},{"date":"2026.08.03","price":"-0.96","value":"0.14"},{"date":"2026.07.31","price":"2.21","value":"2.21"},{"date":"2026.07.30","price":"-2.73","value":"-2.19"},{"date":"2026.07.29","price":"1.10","value":"0.94"},{"date":"2026.07.28","price":"-4.52","value":"-1.95"},{"date":"2026.07.27","price":"2.72","value":"3.13"},{"date":"2026.07.24","price":"-2.47","value":"-3.95"},{"date":"2026.07.23","price":"0.44","value":"-0.26"},{"date":"2026.07.22","price":"-1.42","value":"-0.90"},{"date":"2026.07.21","price":"4.81","value":"-0.66"},{"date":"2026.07.20","price":"-0.71","value":"0.38"},{"date":"2026.07.17","price":"-5.40","value":"-7.01"},{"date":"2026.07.16","price":"-1.97","value":"0.36"},{"date":"2026.07.15","price":"-0.97","value":"2.67"},{"date":"2026.07.14","price":"2.77","value":"2.74"},{"date":"2026.07.13","price":"-3.48","value":"-1.36"},{"date":"2026.07.10","price":"-2.29","value":"3.33"}]
深证成指,生物制品行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 义翘神州 | 53.96% | 59.82% | 5.4分 |
| 2 | - | 42.90% | 11.04% | 分 |
| 3 | 诺唯赞 | 28.57% | 33.30% | 7.4分 |
| 4 | 百普赛斯 | 27.96% | 33.84% | 6.4分 |
| 5 | 艾迪药业 | 22.49% | 26.83% | 6.4分 |
| 6 | 近岸蛋白 | 19.79% | 32.61% | 6.3分 |
| 8 | 派林生物 | 14.97% | 1.63% | 5.5分 |
| 10 | 智飞生物 | 10.76% | 3.37% | 5.6分 |
| 12 | 博晖创新 | 8.79% | 4.21% | 5.6分 |
| 14 | 辽宁成大 | 7.82% | 0.09% | 5.6分 |
| 16 | 百克生物 | 6.19% | 4.69% | 6.2分 |
| 18 | 康希诺 | 5.83% | 8.13% | 5.9分 |
| 20 | 我武生物 | 5.29% | 5.16% | 6.0分 |
| 22 | 甘李药业 | 4.84% | 1.40% | 6.3分 |
| 24 | 西藏药业 | 4.02% | 2.28% | 6.0分 |
| 26 | 天坛生物 | 3.82% | -2.65% | 5.0分 |
| 28 | 成大生物 | 3.52% | 2.85% | 5.7分 |
| 30 | 四环生物 | 2.71% | 15.51% | 5.9分 |
| 32 | 康华生物 | 1.28% | 4.41% | 5.7分 |
| 34 | 金迪克 | 0.58% | 12.35% | 5.5分 |
| 36 | 沃森生物 | 0.00% | 6.66% | 6.1分 |
| 38 | 百奥泰 | -0.54% | 8.42% | 5.8分 |
| 40 | 赛升药业 | -1.03% | 9.43% | 5.7分 |
| 42 | 卫光生物 | -1.99% | 4.07% | 4.9分 |
| 44 | - | -2.45% | 7.28% | 分 |
| 46 | 迈威生物 | -4.27% | 6.38% | 5.5分 |
| 48 | 东宝生物 | -5.89% | 3.77% | 5.8分 |
| 50 | 三生国健 | -11.08% | 15.07% | 6.4分 |
| 52 | - | -18.14% | 11.57% | 分 |
| 54 | 欧林生物 | -38.64% | 26.30% | 6.5分 |
行业评级
最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
- 综合评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 中信证券 | 2012-09-10 | 增持 | 增持 |
| 招商证券 | 2012-09-08 | 增持 | 增持 |
| 航天证券 | 2012-09-06 | 增持 | - |
| 中银国际 | 2012-09-05 | 增持 | - |
| 齐鲁证券 | 2012-09-05 | 增持 | - |
更多>>行业资讯
- 2012-09-13亿利能源股权质押登记
- 2012-09-13太极集团修改《公司章程》
- 2012-09-13人福医药获得国家补助资金
- 2012-09-13常山药业：归还暂时用于补充流动资金的闲置募集资金
- 2012-09-13贵州百灵：公司与济南百诺医药科技开发有限公司签订技
- 2012-09-13振东制药山西省第三建筑工程公司承建山西振东泰盛制药
- 2012-09-13双成药业：战略合作框架协议进展
- 2012-09-13佛慈制药：签订推荐恢复上市、委托代办股份转让协议
- 2012-09-13昊海生科IPO资产被疑是大江股份上市募投项目
- 2012-09-13泰格医药涨势猛 业务有望快速扩张
基本面诊股
[ 截止日期：2026-03-31 ]公司经营
盈利能力：很强，居行业前列，两项指标的行业排名分别为 6/71 ， 20/71。
[{"date":"2026-03-31","value":"3.60","vol":"-6.01"},{"date":"2025-12-31","value":"16.94","vol":"-12.99"},{"date":"2025-09-30","value":"13.30","vol":"-10.09"},{"date":"2025-06-30","value":"9.06","vol":"-0.66"},{"date":"2025-03-31","value":"5.09","vol":"-0.34"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
3.60 | 16.94 | 13.30 | 9.06 | 5.09 |
| 行业(%) | -6.01 | -12.99 | -10.09 | -0.66 | -0.34 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"75.59","vol":"61.43"},{"date":"2025-12-31","value":"75.70","vol":"66.53"},{"date":"2025-09-30","value":"75.97","vol":"67.71"},{"date":"2025-06-30","value":"76.45","vol":"66.67"},{"date":"2025-03-31","value":"76.96","vol":"38.38"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
75.59 | 75.70 | 75.97 | 76.45 | 76.96 |
| 行业(%) | 61.43 | 66.53 | 67.71 | 66.67 | 38.38 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：偏弱，与行业平均有较大差距，两项指标的行业排名分别为 45/71 ， 29/71。
[{"date":"2026-03-31","value":"-13.84","vol":"297.05"},{"date":"2025-12-31","value":"4.36","vol":"39.85"},{"date":"2025-09-30","value":"2.15","vol":"45.81"},{"date":"2025-06-30","value":"-0.51","vol":"6902.14"},{"date":"2025-03-31","value":"-4.17","vol":"6125.11"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
-13.84 | 4.36 | 2.15 | -0.51 | -4.17 |
| 行业(%) | 297.05 | 39.85 | 45.81 | 6902.14 | 6125.11 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"-19.82","vol":"74.22"},{"date":"2025-12-31","value":"4.00","vol":"33.79"},{"date":"2025-09-30","value":"-6.48","vol":"45.67"},{"date":"2025-06-30","value":"-11.92","vol":"5.21"},{"date":"2025-03-31","value":"-4.02","vol":"-8.79"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
-19.82 | 4.00 | -6.48 | -11.92 | -4.02 |
| 行业(%) | 74.22 | 33.79 | 45.67 | 5.21 | -8.79 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：很强，居行业前列，两项指标的行业排名分别为 7/71 ， 6/71。
[{"date":"2026-03-31","value":"0.10","vol":"0.06"},{"date":"2025-12-31","value":"0.50","vol":"0.29"},{"date":"2025-09-30","value":"0.38","vol":"0.21"},{"date":"2025-06-30","value":"0.26","vol":"0.13"},{"date":"2025-03-31","value":"0.12","vol":"0.06"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.10 | 0.50 | 0.38 | 0.26 | 0.12 |
| 行业(次) | 0.06 | 0.29 | 0.21 | 0.13 | 0.06 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"0.50","vol":"0.29"},{"date":"2025-12-31","value":"2.34","vol":"1.29"},{"date":"2025-09-30","value":"1.64","vol":"0.90"},{"date":"2025-06-30","value":"1.05","vol":"0.55"},{"date":"2025-03-31","value":"0.49","vol":"0.25"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
0.50 | 2.34 | 1.64 | 1.05 | 0.49 |
| 行业(次) | 0.29 | 1.29 | 0.90 | 0.55 | 0.25 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：数据暂时不全，请后续关注
[{"date":"2026-03-31","value":"26.00","vol":"-78.67"},{"date":"2025-12-31","value":"44.94","vol":"12.85"},{"date":"2025-09-30","value":"35.71","vol":"0.21"},{"date":"2025-06-30","value":"18.27","vol":"-1377.65"},{"date":"2025-03-31","value":"31.05","vol":"-2083.82"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | 26.00 | 44.94 | 35.71 | 18.27 | 31.05 |
| 行业 | -78.67 | 12.85 | 0.21 | -1377.65 | -2083.82 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"","vol":"0.00"},{"date":"2025-12-31","value":"1.00","vol":"1.74"},{"date":"2025-09-30","value":"","vol":"0.00"},{"date":"2025-06-30","value":"0.52","vol":"1.55"},{"date":"2025-03-31","value":"","vol":"0.00"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | - | 1.00 | - | 0.52 | - |
| 行业 | 0.00 | 1.74 | 0.00 | 1.55 | 0.00 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：很强，居行业前列，两项指标的行业排名分别为 31/71 ， 33/71。
[{"date":"2026-03-31","value":"4.30","vol":"6.66"},{"date":"2025-12-31","value":"3.74","vol":"5.80"},{"date":"2025-09-30","value":"3.78","vol":"6.07"},{"date":"2025-06-30","value":"3.36","vol":"6.57"},{"date":"2025-03-31","value":"3.07","vol":"7.73"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 流动比率 |
4.30 | 3.74 | 3.78 | 3.36 | 3.07 |
| 行业 | 6.66 | 5.80 | 6.07 | 6.57 | 7.73 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"3.66","vol":"5.14"},{"date":"2025-12-31","value":"3.08","vol":"4.43"},{"date":"2025-09-30","value":"3.05","vol":"4.89"},{"date":"2025-06-30","value":"2.63","vol":"5.24"},{"date":"2025-03-31","value":"2.61","vol":"6.33"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 速动比率 |
3.66 | 3.08 | 3.05 | 2.63 | 2.61 |
| 行业 | 5.14 | 4.43 | 4.89 | 5.24 | 6.33 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：尚可，接近行业平均，两项指标的行业排名分别为 32/71 ， 35/71。
[{"date":"2026-03-31","value":"13.42","vol":"28.78"},{"date":"2025-12-31","value":"14.62","vol":"28.75"},{"date":"2025-09-30","value":"14.81","vol":"28.02"},{"date":"2025-06-30","value":"15.83","vol":"26.19"},{"date":"2025-03-31","value":"16.52","vol":"26.65"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
13.42 | 14.62 | 14.81 | 15.83 | 16.52 |
| 行业(%) | 28.78 | 28.75 | 28.02 | 26.19 | 26.65 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"0.16","vol":"2.54"},{"date":"2025-12-31","value":"0.18","vol":"1.42"},{"date":"2025-09-30","value":"0.18","vol":"0.58"},{"date":"2025-06-30","value":"0.20","vol":"1.11"},{"date":"2025-03-31","value":"0.21","vol":"0.80"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
0.16 | 0.18 | 0.18 | 0.20 | 0.21 |
| 行业(%) | 2.54 | 1.42 | 0.58 | 1.11 | 0.80 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构预测
机构预测该股2026年每股收益与前一年相同，长期投资价值一般。
[{"date":"2022","yellowRectValue":"7.03","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"8.47","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"7.07","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"7.35","blueLineValue":"","type":""},{"date":"2026","yellowRectValue":"8.29","blueLineValue":"0.50","type":"YC"}]